These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18822900)

  • 1. [Treatment of chronic hepatitis C virus infection in hemodialysis patients].
    Kaya S
    Mikrobiyol Bul; 2008 Jul; 42(3):525-34. PubMed ID: 18822900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C in dialysed patients--what is the current optimal treatment?
    Kes P; Basic-Jukic N
    Kidney Blood Press Res; 2007; 30(3):156-61. PubMed ID: 17446715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit.
    Covic A; Maftei ID; Mardare NG; Ioniţă-Radu F; Totolici C; Tuţă L; Golea O; Covic M; Volovăţ C; Gusbeth-Tatomir P; Mircescu G
    J Nephrol; 2006; 19(6):794-801. PubMed ID: 17173254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.
    Escudero A; Rodríguez F; Serra MA; Del Olmo JA; Montes F; Rodrigo JM
    J Gastroenterol Hepatol; 2008 Jun; 23(6):861-6. PubMed ID: 18422960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C in hemodialysis patients.
    Berenguer M
    Hepatology; 2008 Nov; 48(5):1690-9. PubMed ID: 18972442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection.
    Chan TM; Ho SK; Tang CS; Tse KC; Lam MF; Lai KN; Yung S
    Nephrology (Carlton); 2007 Feb; 12(1):11-7. PubMed ID: 17295655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.
    Kokoglu OF; Uçmak H; Hosoglu S; Cetinkaya A; Kantarceken B; Buyukbese MA; Isik IO
    J Gastroenterol Hepatol; 2006 Mar; 21(3):575-80. PubMed ID: 16638102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection.
    Akhan SC; Kalender B; Ruzgar M
    Infection; 2008 Aug; 36(4):341-4. PubMed ID: 18629437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
    Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
    Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of pegylated interferon alpha-2a in HCV-positive hemodialysis patients.
    Ucmak H; Kokoglu OF; Hosoglu S; Dogan E; Sayarlioglu H; Kuzhan N; Isik IO
    Ren Fail; 2008; 30(2):227-32. PubMed ID: 18300126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of a common problem in hemodialysis patients: is the juice worth the squeeze?
    Al-Saran K; Sabry A; Shaheen N; Yehia A
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):876-82. PubMed ID: 19736496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C.
    Koksal I
    J Gastroenterol Hepatol; 2006 Mar; 21(3):491-4. PubMed ID: 16638088
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis.
    Kojima A; Kakizaki S; Hosonuma K; Yamazaki Y; Horiguchi N; Sato K; Kitahara T; Mori M
    J Gastroenterol Hepatol; 2013 Apr; 28(4):690-9. PubMed ID: 23302054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C.
    van Leusen R; Adang RP; de Vries RA; Cnossen TT; Konings CJ; Schalm SW; Tan AC
    Nephrol Dial Transplant; 2008 Feb; 23(2):721-5. PubMed ID: 18042614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Good virological response to pegylated interferon alfa monotherapy of chronic hepatitis C infection in hemodialysis patient].
    Caro P; Núñez A; Delgado R; Dapena F; Amann R
    Nefrologia; 2007; 27(1):77-80. PubMed ID: 17402884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey.
    Kose S; Gurkan A; Akman F; Kelesoglu M; Uner U
    J Gastroenterol; 2009; 44(4):353-8. PubMed ID: 19277451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of treatment with pegylated interferon alpha 2A for chronic hepatitis C virus in kidney transplant candidates on hemodialysis.
    Casanovas-Taltavull T; Baliellas C; Llobet M; Cruzado JM; Castellote J; Casanova A; Niubó J; Valls C; Serrano T
    Transplant Proc; 2007 Sep; 39(7):2125-7. PubMed ID: 17889113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of hepatitis C: from empiricism to eradication.
    Pawlotsky JM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S207-20. PubMed ID: 16447262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C infection associated with renal disease and chronic renal failure.
    Poordad FF; Fabrizi F; Martin P
    Semin Liver Dis; 2004; 24 Suppl 2():69-77. PubMed ID: 15346249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.